找回密码
 新注册用户
搜索
楼主: vmzy

[独立平台] [生命科学类] Folding@Home

[复制链接]
 楼主| 发表于 2013-12-18 09:24:01 | 显示全部楼层
Changes to the bigadv threshold
December 17, 2013 by Peter Kasson ·
We have a policy of periodically re-evaluating the bigadv program, including the threshold required to run bigadv projects.
It is the intent of bigadv to match large and resource-intensive work units with some of the most powerful machines used by FAH donors.  This “most powerful” line naturally advances with computing power.  To date, bigadv has been a CPU-based program, and with increasing numbers of CPU cores and power of those cores, we have decided to lay out a roadmap of bigadv threshold changes for the next several months.
Feb 17 (two months from today):  bigadv threshold will become 24 cores
Apr 17 (four months from today):  bigadv threshold will become 32 cores
We want to give advance notice of these changes, and we recognize that change is not always welcome or comfortable.  We should also emphasize that the science performed by donor machines is valuable in all parts of the FAH project, and part of the change in bigadv threshold is because we would like to encourage moderately powerful machines to help boost the capabilities of non-bigadv SMP projects where we do a lot of this science.
We also recognize that core count is not the most robust metric of machine capability, but given our current infrastructure it is the most straightforward surrogate to evaluate.
Thank you once again for your generous participation in the Folding@Home project!
大意:
BA上调cpu数下限。计划2月17号,调成24T。4月17号调成32T。
回复

使用道具 举报

 楼主| 发表于 2013-12-21 16:17:07 | 显示全部楼层
Key new results published in Nature Chemistry
December 20, 2013 by Vijay Pande ·
A key new work from the Pande Group just came out in Nature Chemistry and got a nice holiday present: our work on the cover!
Briefly, we applied methods developed and honed on Folding@home to Google Exacycle (Google’s massively parallel cloud resource — a lot like running Folding@home behind their firewall).  The resources that Google donated to PG/Folding@home was pretty massive, allowing us to tackle a really significant and challenging problem in biology and drug design.
Specifically, we were able to study the protein dynamics of B2AR, a G-Protein Coupled Receptor (GPCR) important in many medical and biological processes (especially asthma and heart disease).  What’s even more exciting to us is that this opens the door for FAH and our methods to be much more broadly applied.  In fact, this is just the first of several papers in the pipeline using FAH and FAH-like methods to tackle challenging biomedical problems.
For more information, you can also check out Stanford’s news’ coverage on this.

大意:
在《自然--化学》杂志发表软文。主要讲利用谷歌的集群服务器,研究B2AR(与哮喘、心脏病有关)的蛋白质动力学。
回复

使用道具 举报

 楼主| 发表于 2013-12-24 11:12:40 | 显示全部楼层
Happy Holidays! Looking back at 2013 and forward to 2014 …
December 23, 2013 by Vijay Pande ·
As the year ends, it’s a natural time to look at some key highlights of we’ve done in 2013 and look ahead to what’s on deck for 2014.  One of the challenges of science results can easily take a year for us to run on FAH, analyze, and publish.  So, the work of 2012 comes out in 2013 and the projects running in 2013 get to reach the public in 2014.  So, it makes sense to talk about both work that’s been going on this year and how all of this will shape up in 2014.  We’ve been doing a lot behind the scenes in 2013 and I’m excited about all of this getting out to the public in 2014.  Here are some key developments.

FAH development in 2013.  We’ve had several new developments in how FAH works, from both the donor perspective as well as how FAH works behind the scenes.  With the addition of new programmer Yutong “Proteneer” Zhao, Core 17 was a big advance for FAH.  It brought the most advanced features from the OpenMM GPU code, especially major speed increases for AMD/ATI cards.  Moreover, it also brought a natural path to true Linux GPU support and lots of useful scientific updates.  The v7 client continues to advance, with a new web interface; these simplifications have been important especially for certain partners who have wanted to see an easier to use FAH client before they can help us push for greater deployment.  Adaptive sampling approaches have been a part of how FAH works, but we’ve also been moving to automate this process, leading to more powerful ways we can use the power of the FAH clients.

New FAH results.  Several of our long running projects have come to fruition in 2013 and gotten various honors.  One major result which also gives a good idea of where we’re going in the future was our work on GPCRs, key proteins at the heart of much of disease and drug design.  Our work on GPCRs, running a FAH-like infrastructure on Google’s internal processors, sets the stage for similar calculations to be run on FAH (as I’ll describe below).  In a nutshell, what we’ve been able to show is that the tools used to understand protein folding (developed in FAH) can shed light on how GPCRs behave, especially revealing intermediate structures which are interesting and potentially important new targets for drug design.

New projects.  Kinases are key drug targets for cancer.  2013 brought new projects which will lead to new papers in 2014.  Many donors have asked us to push into more areas in cancer and our pilot projects have worked out well, leading to full fledged FAH projects in cancer.  Our first paper in this area has been submitted, with several more in the pipeline.  I’ll post more when the paper is out, but briefly, we’ve been able simulate kinase dynamics, identifying new intermediate states that could be useful drug targets.  Our goal is to help develop kinase drugs with greater specificity, leading to a dramatic improvement in cancer therapies, especially without the devastating issues of current chemotherapies, which comes from the fact that current drugs are not very specific to a give kinase and affect the whole body—not just the tumor cells—in a very negative manner.  We also now have some very high power collaborators on board, including those at the Memorial Sloan Kettering Cancer Center in New York.  We also have new results in Alzheimer’s Disease and Infectious Disease which we are in the process of submitting for publication.  These results are in the area of drug repurposing, leading to the ability of the FAH team to go straight to therapies for these diseases using combinations of existing drugs; we’ve very excited about this direction as it allows us to go quickly to phase 2 clinical trials, getting new drugs in the hands of patients decades before other methods would.

Looking to the future of FAH: on deck for 2014.  We’ve been working behind the scenes with various partners to get Folding@home disseminated into more people’s hands, increasing what we can all do together.  We expect to release a whole new type of client and backend server in 2014, which will help make it easier and easier for many donors to contribute to FAH.   Also, we’ve gotten a lot of useful responses to the donor survey and we’re working to implement the most important suggestions.  Specifically, we’re hiring a new position solely for donor relations.  We hope that this will solve the challenge of the science team having to decide between donor relations and getting their science done, by having someone whose sole role is donor relations.  Finally, we have several partnerships with companies who have been working to promote Folding@home that we will hopefully be able to announce in 2014.

For us, it’s a very exciting time.  2013 was very much a year of laying seeds for 2014.  The key elements are an improved client and more powerful set of cores (especially GPU core17) combined with new backend methods, applied to key new scientific projects running in 2013 in the areas cancer, Alzheimer’s Disease, and infectious disease.  All of this, pushed forward by a lot of raw power from partnering could easily make 2014 a landmark year for FAH.  We’d like to thank all of the donors who make this possible and look forward to hopefully working together to make 2014 the best year FAH has ever seen.
大意:
剩蛋快乐之2013年终总结。
又到年底了,该写年终总结了,我们也不例外。一般情况下我们计算、分析、发表论文大概要1年时间,所以13年的成就大部分来自于12年的工作,而今年的工作,要到14年才有体现。那么现在就让我们回顾过去,展望未来吧。
2013总结之开发篇。由于赵宇桐的加盟,开发了core 17版GPU内核,给显卡计算效率带来质的飞跃,同时也加入很多新功能,也对linux GPU提供了原生支持。V7客户端加入了网页界面,简化了操作。同时为FAH加入了智能采样算法,让我们能更好的利用FAH的计算力(译注:我也不太清楚这是个什么东东)。
2013总结之新结果。利用谷歌的内部服务器集群,我们对GPCRs进行了详细研究,为将来的药物设计研究打下坚实基础。
2013总结之新项目。很多志愿者要我们加强癌症方面的研究力度,而激酶是抗癌药物的关键,所以2013年的工作重心放在了激酶上。第一篇论文已经提交了,其他后续文章正在积极准备中。一旦有新消息我会及时告知大家。通过对激酶的研究,我们发现了很多新的可用于药物研发的中间态。这可以使将来研发的药物,更具有靶向性,效果更佳。(众所周知,目前普遍使用的化疗,木有靶向性,不但攻击癌细胞,也攻击正常细胞,副作用极大)。而且Memorial Sloan Kettering癌症研究中心的加盟,也使我们如虎添翼。老年痴呆症和传染病方面的研究也有重大突破,新论文正在发表中。研究的主要方向是药物重利用,即在现有药物中寻找可以混合起来治疗疾病的鸡尾酒新药。这样‘新药’就可以直接进行2期临床阶段,这种方法至少比其他方法能提前十年进入临床使用。
展望2014:希望能加大宣传让更多的人加入FAH。发布新的更加人性化的客户端和服务器端。专门雇佣了志愿者关系维护人员,搞好与志愿者们的沟通(译注:看到这句,我蛋疼的不行了!)。2014将有更多的合作者加盟。
就剩一句了:2013主要升级了客户端和内核(尤其是core 17)。项目方面主要研究了癌症、老年痴呆症、传染病。在更多服务器集群加盟的情况下,FAH的算力将取得突破。希望和大家共创2014年的辉煌。谢谢大家!

评分

参与人数 2基本分 +110 收起 理由
cicikml + 100 辛苦了!V版积分果然高!
金鹏 + 10 辛苦了!

查看全部评分

回复

使用道具 举报

发表于 2013-12-31 10:27:40 | 显示全部楼层
本帖最后由 vmzy 于 2013-12-31 17:19 编辑

Bowman lab updateDecember 29, 2013 by Greg Bowman ·
I started a few projects to study the dynamics of a protein called dihydrofolate reductase (or just DHFR for short) a few months ago and now have enough data to begin analysis.  DHFR is an exciting protein to study because it is an important target for both anticancer and antibacterial drugs.  There is also substantial experimental evidence that DHFR’s conformational dynamics are important for its function but our understanding of these dynamics is still incomplete.  More detailed insights from these projects could provide insight into how to manipulate DHFR’s dynamics for therapeutic purposes.

Filed Under: Uncategorized ·
大意:
之前鲍曼实验室对二氢叶酸还原酶(缩写:DHFR) 进行了研究,目前已取到足够数据,开始数据分析了。DHFR在抗癌和抗菌药物研究方面意义重大。事实证明,DHFR的构型动力学对药物研发至关重要,不过我们现在对此了解还不够深入。希望我们能借此机会对DHFR蛋白进行更加深入的研究。
回复

使用道具 举报

 楼主| 发表于 2014-1-3 09:42:34 | 显示全部楼层
FAH VM server down, sys admins notified
January 2, 2014 by Vijay Pande ·
A key FAH VM server is down, which means that stats updates are on hold (but points are still being kept on the WS’s, just not reported to the web site) and also the GPU AS is down.  We will post an update when we know more.  Unfortunately, Stanford is shutdown this week, so the sysadmins are on a reduced schedule, so the response time will be longer than normal.
大意:
FAH的统计服务器和GPU发包服务器宕机了。不幸的是,现在正值圣诞假期(相当于我朝春节),攻城狮的修复速度会异常缓慢。

VM server back up & plan to improve this for next time
January 2, 2014 by Vijay Pande ·
The VM server is back up, so the key services (asssign2, assign-GPU, and stats) are now back up.  Right now, there is no assign-GPU2 (backup GPU AS) and, considering the importance of GPU WUs, we’ll get that up next week.  We architected support for this some time ago, so all v7 clients should be able to use that redundant AS, so if one goes down, one can still get WUs.
大意:
服务器基本上恢复正常了。但是assign-GPU2依然挺尸中。预计下周恢复。不过v7客户端可以自动跳转到冗余GPU服务器,理论上影响不大。
回复

使用道具 举报

 楼主| 发表于 2014-1-4 10:39:10 | 显示全部楼层
More core17 WUs are on the way
January 3, 2014 by Vijay Pande ·
We see a shortage in Core17 WUs, so we’re building more core17 WUs right now.  The building process takes some time, probably until tomorrow morning.  By then, there will be plenty of Core17 WUs.
大意:
一大波core17 任务即将袭来。

fahnd03/04 maintenance Jan 3-4
by abdulwahidc » Fri Jan 03, 2014 11:17 pm

These two servers will be intermittently from Friday Jan 3 through Sunday as our university is upgrading infrastructure and doing maintenance.

fahnd03: 129.74.246.143
fahnd04: 129.74.246.144
大意:
两台服务器将进行例行维护。影响应该不大。
回复

使用道具 举报

 楼主| 发表于 2014-1-7 09:17:02 | 显示全部楼层
VM server went down again — back up now
January 6, 2014 by Vijay Pande ·
The VM server went down again last night.  It’s back up now, but I’m not happy that this has happened so frequently.  We’re looking into what’s going on here.  Later this week, we’ll have a redundant GPU AS which will minimize the impact of this machine going down, but still we need to find out the root of what’s going on here.  It’s possible that VM server is hitting end of life and having some hardware issues.
大意:
服务器又挂了。不过现在已经恢复了。不知道服务器为何如此频繁的宕机,接下来我们会仔细查找原因,也许是硬件寿命到了。周末我们会增加一台冗余的GPU服务器。
回复

使用道具 举报

发表于 2014-1-9 10:54:44 | 显示全部楼层
Webinar: Learn about OpenMM, the code driving FAH GPUs

January 8, 2014 by Vijay Pande ·
For those that are curious about OpenMM, the code that drives the GPU calculations in FAH, please join us on January 16th for a webinar presented by Professor Vijay Pande.  I’ll talk about about OpenMM, the computational engine behind the Folding@Home distributed computing system, and hear how others have leveraged its high-performance on GPUs and its custom classes and extreme flexibility to accelerate research in areas such as free energy calculations, protein folding, and protein conformational change.
This webinar is planned for January 16th 2014 at 9.00 AM Pacific Time. Space is limited, so please register at http://bit.ly/OpenMM

Filed Under: Uncategorized ·



回复

使用道具 举报

发表于 2014-1-9 10:55:41 | 显示全部楼层
本帖最后由 vmzy 于 2014-1-9 11:27 编辑

An Introduction to Markov State Models



January 8, 2014 by Vijay Pande ·
For researchers curious about how FAH efficiently uses thousands to hundreds of thousands of processors, we’ve recently put together a new book which describes these Markov State Model methods in detail.
The aim of this book is to explain the importance of Markov state models to molecular simulation, how they work, and how they can be applied to a range of problems. The Markov state model (MSM) approach aims to address two key challenges of molecular simulation:
1) How to reach long timescales using short simulations of detailed molecular models
2) How to systematically gain insight from the resulting sea of data
MSMs do this by providing a compact representation of the vast conformational space available to biomolecules by decomposing it into states—sets of rapidly interconverting conformations—and the rates of transitioning between states. This kinetic definition allows one to easily vary the temporal and spatial resolution of an MSM from high-resolution models capable of quantitative agreement with (or prediction of) experiment to low-resolution models that facilitate understanding. Additionally, MSMs facilitate the calculation of quantities that are difficult to obtain from more direct MD analyses, such as the ensemble of transition pathways.
This book introduces the mathematical foundations of Markov models, how they can be used to analyze simulations and drive efficient simulations, and some of the insights these models have yielded in a variety of applications of molecular simulation.

For those who are curious for a less detailed introduction, this on-line seminar from FAH team members is also useful:


Filed Under: Uncategorized ·
大意:
最近我们出了本新书,详细介绍了马尔可夫状态模型法,阐述了FAH是如何高效利用成千上万处理器资源的。
本书的目的是解释了马尔可夫状态模型法在分子模拟方面的重要作用。它解决了2个关键问题:
1、如何利用短时间模拟的分子模型细节,完成长时间模拟。
2、如何从海量的数据中系统挖掘有用的信息。
MSM通过把大量的分子生物分构型信息压缩为不同的状态以及状态间的转换速度信息。这种动力学描述,可以轻易的将高分辨率的海量信息在时间与空间上压缩为低分辨率的易理解的信息。此外,MSMs还可以推算出传统分子动力学算法无法直接计算出的信息。
本书介绍了马尔可夫状态模型法的数学原理,以及如何利用来高效的进行模拟。
有兴趣的可以看下FAH团队的讨论会在线视频(译注:需翻墙,你懂的):
http://www.youtube.com/embed/0pB3pUXULmo?feature=oembed







Webinar: Learn about OpenMM, the code driving FAH GPUs
January 8, 2014 by Vijay Pande ·
For those that are curious about OpenMM, the code that drives the GPU calculations in FAH, please join us on January 16th for a webinar presented by Professor Vijay Pande.  I’ll talk about about OpenMM, the computational engine behind the Folding@Home distributed computing system, and hear how others have leveraged its high-performance on GPUs and its custom classes and extreme flexibility to accelerate research in areas such as free energy calculations, protein folding, and protein conformational change.

This webinar is planned for January 16th 2014 at 9.00 AM Pacific Time. Space is limited, so please register at http://bit.ly/OpenMM
大意:
将于1月16日,Vijay Pande讲授召开有关GPU核心算法OpenMM的网络研讨会。名额有限,有识之士尽快去注册报名。
回复

使用道具 举报

 楼主| 发表于 2014-1-10 09:46:44 | 显示全部楼层
Working with Apple on GPU support
January 9, 2014 by Vijay Pande ·
There’s not a lot to report just yet, but we’ve made some progress in terms of Apple engaging us on the bugs we’ve filed some time ago that are keeping us from supporting our GPU code (OpenMM) on OSX.  No promises here, but at least there’s some progress.
大意:
就OSX系统的GPU内核支持问题与苹果公司展开初步合作。


New backup GPU Assignment Server update
January 9, 2014 by Vijay Pande ·
We’re happy to report that we’ve got a backup GPU AS online.  As with any of our servers, you can say “hi” and test your connection to it manually by sending your browser to it:  http://assign-gpu2.stanford.edu (you’ll see it say “OK” if you can get through).

The use of backup GPU AS is new to the FAH infrastructure and we now see that to make it work, we’ll need to roll out a new client.  That has now become the top code development priority.
大意:
新的GPU备用发包服务器正式上线。为了能使它更好的发挥作用,升级新版客户端成了首要大事。
回复

使用道具 举报

发表于 2014-1-10 14:47:09 | 显示全部楼层
本帖最后由 vmzy 于 2014-1-11 10:14 编辑

Getting ready for the new GPU AS

January 10, 2014 by Vijay Pande ·
We’ve done some serverstat tweaks for the new GPU AS, namely to include a row for that AS (so donors can see if it’s up) and a column for WS’s that were assigned by it.  We’re also planning to have a new client in beta testing with support for the new GPU AS (amongst other improvements) soon, hopefully entering beta testing on January 10, 2014 (California time).

Filed Under: Uncategorized ·
大意:
新GPU AS服务器上线,统计页面也做了相应调整。支持新GPU AS服务器的新版客户端,将于明天或后天发布。大家敬请期待!



Backend work
January 10, 2014 by Vijay Pande ·
We’ve been doing work on the FAH backend servers.  We had to take the stats down for a bit longer than we liked.  They’re back up now.  Sorry for the delay in getting those points recorded.
大意:
服务器维护完成,现在统计系统也恢复正常了,分数悉数补上了。
回复

使用道具 举报

 楼主| 发表于 2014-1-12 09:48:05 | 显示全部楼层
Progress with OpenMM on OSX
January 11, 2014 by Vijay Pande ·
In working with Apple, we’ve been making good progress with OpenMM (our GPU code, the heart of core17) on OSX.  While we can’t promise anything just yet, this was encouraging.  For those who are curious, you can watch our development in the open (OpenMM is of course, Open Source software) at our github repo commits link:

https://github.com/SimTk/openmm/commits/master大意:
在苹果公司的大力协助下,OSX平台的OpenMM 库开发进展非常顺利。
回复

使用道具 举报

 楼主| 发表于 2014-1-13 10:09:58 | 显示全部楼层
New client in beta test: v7.4.0
January 12, 2014 by Vijay Pande ·
We’ve released a new client version for beta testing.  This release adds a new and improved Web interface which is cleaner, hopefully more intuitive and displays your personal and team points. In addition, there are a number of bug fixes and enhancements over the last public v7.3.6 release.  This version also includes access to the new GPU backup Assignment server.

Details can be found in a thread in the folding forum.
大意:
发布新测试版客户端v7.4.0。此版本改进了网页版界面,更漂亮了,加入了个人和团队的积分显示。此外修正了一堆bug。并且加入了对GPU备用AS服务器的支持。


Survey summary
January 12, 2014 by Vijay Pande ·
Vickie Curtis has written a summary of her survey work, outlining the main findings.  We’ve found this survey very useful and have made some internal changes in order to take advantage of some of the findings there, especially in terms of improving donor communications.  You can find her summary here:  Survey Summary – F@H Participants
大意:
之前Vickie Curtis做的志愿者调查,目前发布了调查报告概要。鸟语好的可以去看下。
回复

使用道具 举报

 楼主| 发表于 2014-1-15 09:54:08 | 显示全部楼层
Fighting cancer on Folding@Home: EGFR
January 14, 2014 by john Chodera ·
[Guest post by Daniel L. Parton of the Chodera Lab, Memorial Sloan-Kettering Cancer Center.]

We’re about to roll out our first major F@h project on the new work server at Memorial Sloan-Kettering Cancer Center (MSKCC). Our chosen target is a protein known as the epidermal growth factor receptor (EGFR), which is a member of the kinase family of human proteins. Kinases are key components in cellular signaling pathways, which control and coordinate all cellular activities. When kinases are activated, they pass messages to other proteins by attaching small phosphate molecules to specific parts of their structure. For proper regulation of signaling pathways, the cell must also be able to temporarily inactivate kinases. However, mutations in kinase genes may cause them to become constantly active, resulting in overactivation of the associated signaling pathways. In some cases, this causes the cell to begin dividing and growing uncontrollably, and this chain of events is the cause of many types of cancer.
EGFR mutations are specifically associated with certain types of cancer of the lung, breast, colon, rectum, and brain. Although a small number of anti-EGFR drugs are available (for example, gefitinib, erlotinib, and cetuximab), the development of resistance mutations during treatment is a huge barrier to their effective use.

The Chodera Lab is working to understand a number of factors which have historically hindered the development of effective kinase drug treatments. Firstly, we are interested in what makes a drug molecule selective for one kinase over another (since there are approximately 500 types of kinase in a human cell with nearly identical active sites). Secondly, we want to understand the physical mechanism by which resistance mutations develop to diminish the therapeutic effect of a drug. Eventually, we also hope to be able to use genetic sequencing data from individual cancer patients to predict which particular drug treatment might be optimal given a particular patient’s tumor mutations. There are many theoretical and algorithmic hurdles that we will need to overcome on the way, but these F@h simulations of EGFR will be a first step towards these goals.

Thanks again to all the F@h donors for contributing their computer time to enable this research!



The team of researchers studying EGFR includes Daniel L. Parton, Patrick M. Grinaway, Kyle A. Beauchamp, and Sonya M. Hanson in the Chodera Lab at MSKCC. Special thanks to Richard Knospler in the MSKCC Open Systems group for all of his hardware and software help in getting our servers up and running!




The epidermal growth factor receptor (EGFR) kinase catalytic domain bound to a small-molecule experimental inhibitor. PDB accession code: 2HZ0. Image by Daniel L. Parton.
大意:
准备在新服务器上上马新的有关癌症研究的大项目。我们选择的目标是表皮生长因子受体(EGFR),它是一种人体激酶。激酶是关键的细胞信号转导通路,控制和协调所有的细胞活动。当激酶激活时,它会通过在特定结果位置绑定小磷酸盐分子的方式向其他蛋白质传递信号。通过适当的调节信号通路,细胞也可以暂时抑制激酶活性。然而激酶的基因变异可以导致他们一直处于激活状态,这将导致信号通路的持续活跃,有时还会导致细胞的分裂和生长失控,这就是肿瘤、癌症发生的根源。EGFR变异与某些特定的癌症有关,虽然目前已经有一些抗EGFR药物了(比如:gefitinib, erlotinib和cetuximab),但开发新的抗激酶变异药物仍然是个难题。
Chodera实验室试图破解激酶药物开发效率低下这个历史性难题。首先,我将对人体细胞中的约500种激酶进行筛选,看哪些适合制药。其次,对激酶的抗药性变异进行物理机制研究。最终,我们希望能实现,通过对癌症患者的基因测序数据,对患者对症下药。虽然在研究的道路上,有很多理论和算法的障碍,但是使用FAH对EGFR进行模拟,为整个研究计划开了个好头。
感谢FAH志愿者的无私奉献。
图片为,绑定了抑制分子的EGFR激酶。PDB访问码为:2HZ0

回复

使用道具 举报

 楼主| 发表于 2014-1-16 14:17:32 | 显示全部楼层
Revised plans for BigAdv (BA) experiment
January 15, 2014 by Vijay Pande ·
We’ve put a lot of time into reading the comments about the BA experiment and have come to some conclusions regarding how we should proceed. BA was originally conceived as an experiment to push FAH as close to what you could run on a traditional supercomputer as possible, doing calculations that most researchers thought could never run on a distributed computing platform. In order to make this possible, the requirements for BA would have to be pretty extreme and constantly updating (much like how supercomputers are constantly being updated to the latest hardware). In recognition of this extreme set of requirements came a very large PPD.

BA was embraced by donors with powerful machines. It also encouraged donors to buy and build powerful machines, which are naturally expensive, in turn leading to donors naturally becoming upset when requirements change. However, updating BA is important. Without updating to keep BA amongst only the top machines in FAH, there would be a huge point inflation (turning off non-BA donors) and also limit what we could do with FAH outside of BA-needed projects.

In the most recent announcement of an update in BA, the reaction was particularly negative. This was far from our intent — we’re here to push our research forward and also to help bring donors together in this important cause we’re all fighting for. The BA update did the opposite. It turned people off from Folding@home and served as an obstacle to our ability to push our research forward.

We’ve listened to the donor comments (including those running BA and those who are not) and come to the following plan to be sensitive to their concerns but also to avoid this sort of issue continuing over and over in the future.

1) The posted change in BA requirements will be revised. The only change in requirements going forward will be to require 24 cores (with according changes in deadlines) and that will occur on May 1, 2014. Why change the minimum core count? In general, FAH works best when we have fewer longer trajectories rather than more slower trajectories, which is why we need to change the BA requirements periodically. Given the amount of BA work we would like to do, the cutoff has to be raised above the current level. While, 32 cores would be ideal but we can still get work done at 24 and, in recognition of donor needs, we will set the level there.

2) The BA experiment will permanently end on January 31, 2015. On that date, the servers will be set to accept only and we will have no plans for future BA WUs. This would allow donors to continue to use their machines and recoup more of their investment than the previous plan. This decision would also work to avoid future issues and strife within the FAH community associated with BA. We understand that many donors will be very disappointed about this decision. This was a judgement call I had to make and this decision is, in my opinion, the right thing to do for the long term good of FAH, even though I know there will be many upset donors right now.

In leading FAH, my approach has been to push the limits, try new experiments, but also keep an eye to the future such that FAH outlasts and out performs other distributed computing projects. Starting with establishing FAH itself over 13 years ago, to pushing to GPUs, true SMP, Playstation 3, and most recently to supercomputer like nodes with BA, we have constantly been trying new directions to see how we can further and further advance our research. All experiments come to an end, sooner or later. I think my team and I have learned a lot from reading the recent posts and it’s time for us to concentrate on the core parts of FAH and improve them and not bite off too much.

Going forward, the next steps will include a discussion of the change of the QRB formula and possibly an update of the benchmark machine. Our plan is to seek more input from donors for both changes. While a distributed computing project cannot be run effectively through polls, I think there is a lot of room for us to improve in terms of connecting to donors and incorporating their concerns. I’m very excited about the future of FAH. I think my team has learned a lot with BA and hopefully we can take that going forward to make FAH even better.

Thanks to all for their contributions and participation in FAH. Working together we have done and will continue to do great things!
大意:
BA修改计划
BA的初衷是鼓励民间超算。但是正如果实现世界中超算的排名一样,超算的标准是在不断提高的。如果不提高标准势必引发FAH的积分通胀。导致积分失衡,非BA项目志愿者大量流失。
之前我们发布了一个BA标准提升计划。结果遭到了大家的一致反对。在看了大家对BA的评论后项目组经过讨论,做出了艰难的决定。
1、14年5月1日起,BA标准改为24T(到期时间也会做相应调整)。BA任务的特点是需要一次性完成长时间的模拟(越长越好)。实际上当前BA任务理想的标准是32T。不过为了照顾大家的感受我们还是定为24T。
2、BA项目将于15年1月31日,永久性终止。这样会防止积分通胀,体现公平性原则,也会结束一直以来在论坛的有关BA合理性的不断争吵。
这一切都是为了FAH的长久发展,请大家理解。
接下来,我们将修改QRB公式,升级项目评分的基准设备。使FAH的积分系统更加平衡。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 新注册用户

本版积分规则

论坛官方淘宝店开业啦~

Archiver|手机版|小黑屋|中国分布式计算总站 ( 沪ICP备05042587号 )

GMT+8, 2024-4-27 08:34

Powered by Discuz! X3.5

© 2001-2024 Discuz! Team.

快速回复 返回顶部 返回列表